DrugDashboards

Market view

pyridostigmine bromide · Granule

2 marketed package NDCs · 2 active manufacturers

Most dispensed: 60 mg · Tablet · #100 tablets/bottle · 60 mg/5mL · Solution · #473 mL/bottle · 180 mg · Tablet, Extended Release · #30 tablet, extended releases/bottle · 60 mg · Tablet · #30 tablets/bottle

All formsTablet (25)Solution (8)Powder (8)Tablet, Extended Release (4)Granule (2)Injection, Solution (1)

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for pyridostigmine bromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Cholinesterase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Pyridostigmine bromide in shortage right now?
No. FDA does not currently list Pyridostigmine bromide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Pyridostigmine bromide?
26 companies have marketed Pyridostigmine bromide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Pyridostigmine bromide cost?
The typical pharmacy pays about $0.5080 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.